ArticleHead & neck2011

Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model.

Daisuke Sano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.